Docoh
Loading...

ILMN Illumina

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Company profile

Ticker
ILMN
Exchange
CEO
Francis deSouza
Employees
Incorporated
Location
Fiscal year end
Former names
ILLUMINA INC
SEC CIK
IRS number
330804655

ILMN stock data

(
)

Calendar

16 Feb 21
18 Apr 21
2 Jan 22
Quarter (USD)
Jan 21 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Jan 21 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Illumina earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 1.81B 1.81B 1.81B 1.81B 1.81B 1.81B
Cash burn (monthly) (positive/no burn) 19.33M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) n/a 67.82M n/a n/a n/a n/a
Cash remaining n/a 1.74B n/a n/a n/a n/a
Runway (months of cash) n/a 90.1 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
6 Apr 21 Jay T Flatley Common Stock Sell Dispose S No Yes 423.435 4,000 1.69M 160,933
6 Apr 21 Tousi Susan H Common Stock Sell Dispose S No Yes 423.435 500 211.72K 44,143
5 Apr 21 Tousi Susan H Common Stock Sell Dispose S No Yes 386.03 300 115.81K 44,643
5 Apr 21 Febbo Phillip G. Common Stock Payment of exercise Dispose F No No 384.54 131 50.37K 5,461
22 Mar 21 Charles Dadswell Common Stock Sell Dispose S No Yes 416.24 314 130.7K 6,832
16 Mar 21 Jay T Flatley Common Stock Sell Dispose S No Yes 421.06 4,000 1.68M 164,933

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

91.4% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 960 876 +9.6%
Opened positions 167 99 +68.7%
Closed positions 83 95 -12.6%
Increased positions 352 358 -1.7%
Reduced positions 312 299 +4.3%
13F shares
Current Prev Q Change
Total value 49.34B 43.36B +13.8%
Total shares 133.38M 131.92M +1.1%
Total puts 1.38M 1.74M -20.7%
Total calls 1.28M 1.55M -17.5%
Total put/call ratio 1.1 1.1 -3.9%
Largest owners
Shares Value Change
Baillie Gifford & Co 19.83M $7.34B +11.9%
Vanguard 11.33M $4.19B -1.3%
BLK Blackrock 11.25M $4.16B -4.2%
Edgewood Management 6.95M $2.57B -2.9%
STT State Street 5.88M $2.18B -3.7%
BK Bank Of New York Mellon 3.7M $1.37B +13.5%
Loomis Sayles & Co L P 3.5M $1.3B -0.0%
Sands Capital Management 2.95M $1.09B -4.1%
MS Morgan Stanley 2.86M $1.06B +9.1%
JHG Janus Henderson 2.74M $1.01B +332.7%
Largest transactions
Shares Bought/sold Change
Baillie Gifford & Co 19.83M +2.11M +11.9%
JHG Janus Henderson 2.74M +2.11M +332.7%
Polen Capital Management 2.33M +1.77M +313.7%
Norges Bank 1.55M +1.55M NEW
Massachusetts Financial Services 454.49K -1.1M -70.8%
Capital World Investors 1.52M -1.1M -42.0%
American Century Companies 144.48K -971.22K -87.1%
ARK Investment Management 50.59K -928.08K -94.8%
Generation Investment Management 1.96M +784.34K +66.5%
Select Equity 505.44K -670.1K -57.0%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: advisory, Altera, APAC, Arnold, attestation, Bank, behavioral, Bluebee, bridge, bring, cBot, certainty, certiorari, Chinese, CircLigase, citizen, climate, collar, Commissioner, consumption, contemplated, COVIDSeq, csr, culture, curate, decide, decree, deep, depart, departing, depressing, desire, divest, duration, embed, EMEA, Enancio, enjoining, entry, EPS, extreme, FastTrack, feel, FGx, footnote, forma, foster, gas, Goldman, great, greenhouse, GRI, healthy, inaccurate, inclusion, ineffective, invocation, jeopardize, KAREN, letter, leverage, lieu, loan, LP, mission, morale, motivate, Northstar, opportunity, organizational, pandemic, pendency, permanent, persistent, petition, pipeline, pro, promulgated, rata, Remote, remotely, renegotiate, Renminbi, replace, restraining, restraint, SASB, spread, steward, stewardship, Supreme, surviving, talent, Task, TCFD, threat, thrive, travel, unavailable, USA, voluntary, waived, waste, water, women, Yuan
Removed: accurate, billing, BlueFish, bona, breached, build, construction, CSPro, deterioration, discrete, Durascript, efficiency, efficiently, fide, financed, fulfillment, group, immaterial, interface, judged, lacked, landlord, malfunction, mentioned, October, offered, partnered, perpetual, pretax, principle, promised, proper, prospectively, provisional, pursue, pursuit, resource, retrospectively, revaluing, rounded, selected, setup, step, unaudited, unrelated, visibility

Patents

GRANT
Utility
Catalyst-free surface functionalization and polymer grafting
13 Apr 21
The present application relates to a method for preparing a functionalized surface and the use in DNA sequencing and other diagnostic applications.
GRANT
Utility
Nucleic acid sequence analysis from single cells
13 Apr 21
Presented herein are methods and compositions for multiplexed single cell gene expression analysis.
GRANT
Utility
System and methods for selective effluent collection
13 Apr 21
A system may include a flow cell through which a plurality of reagents may be pumped during a genetic sequencing operation, an effluent line that, in operation, is to conduct a used reagent, a used reagent valve to receive the used reagent from the effluent line and controllable to select one of a plurality of disposal paths for the used reagent, and control circuitry coupled to the used reagent valve that, in operation, is to control the used reagent valve to select a desired one of the disposal paths depending upon which reagent is being pumped though the flow cell.
GRANT
Utility
In-line pressure accumulator and flow-control system for biological or chemical assays
13 Apr 21
Flow-control system includes a fluid reservoir configured to store a fluid, a pressure accumulator in flow communication with and positioned downstream from the fluid reservoir, and a loading zone that is configured to receive and fluidly couple to a flow cell having a biological or chemical sample.
APP
Utility
High-throughput Single-cell Transcriptome Libraries and Methods of Making and of Using
8 Apr 21
Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells.